Functional distinction of human EAG1 and EAG2 potassium channels

FEBS Lett. 2002 Mar 13;514(2-3):204-8. doi: 10.1016/s0014-5793(02)02365-7.

Abstract

Human ether à go-go potassium channel 2 (hEAG2) was cloned and its properties were compared with the previously characterized isoform hEAG1. In the Xenopus oocyte expression system the time course of activation was about four times slower and the voltage required for half-maximal subunit activation was about 10 mV greater for hEAG2 channels. However, its voltage dependence was smaller and, therefore, hEAG2 channels start to open at more negative voltages than hEAG1. Coexpression of both isoforms and kinetic analysis of the resulting currents indicated that they can form heteromeric channel complexes in which the slow activation phenotype of hEAG2 is dominant. Upon expression in mammalian cells, quinidine blocked hEAG1 channels (IC(50) 1.4 microM) more potently than hEAG2 channels (IC(50) 152 microM), thus providing a useful tool for the functional distinction between hEAG1 and hEAG2 potassium channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells / cytology
  • CHO Cells / drug effects
  • CHO Cells / metabolism
  • Cricetinae
  • Ether-A-Go-Go Potassium Channels
  • Gene Expression
  • Humans
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Microinjections
  • Oocytes / metabolism
  • Patch-Clamp Techniques
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / genetics
  • Potassium Channels / metabolism*
  • Potassium Channels, Voltage-Gated*
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Protein Subunits
  • Quinidine / pharmacology
  • Transfection
  • Xenopus

Substances

  • Ether-A-Go-Go Potassium Channels
  • KCNH1 protein, human
  • KCNH5 protein, human
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Protein Isoforms
  • Protein Subunits
  • Quinidine